- Home
- KROS vs SEAT Comparison
KROS vs SEAT Comparison
Compare KROS & SEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- SEAT
- Stock Information
- Founded
- KROS 2015
- SEAT 2001
- Country
- KROS United States
- SEAT United States
- Employees
- KROS N/A
- SEAT N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- SEAT Industrial Machinery/Components
- Sector
- KROS Health Care
- SEAT Industrials
- Exchange
- KROS Nasdaq
- SEAT Nasdaq
- Market Cap
- KROS 589.8M
- SEAT 622.1M
- IPO Year
- KROS 2020
- SEAT N/A
- Fundamental
- Price
- KROS $11.84
- SEAT $4.70
- Analyst Decision
- KROS Buy
- SEAT Strong Buy
- Analyst Count
- KROS 11
- SEAT 10
- Target Price
- KROS $45.33
- SEAT $6.73
- AVG Volume (30 Days)
- KROS 2.1M
- SEAT 1.3M
- Earning Date
- KROS 02-26-2025
- SEAT 03-04-2025
- Dividend Yield
- KROS N/A
- SEAT N/A
- EPS Growth
- KROS N/A
- SEAT N/A
- EPS
- KROS N/A
- SEAT N/A
- Revenue
- KROS $651,000.00
- SEAT $774,076,000.00
- Revenue This Year
- KROS $303.27
- SEAT $10.17
- Revenue Next Year
- KROS N/A
- SEAT $4.02
- P/E Ratio
- KROS N/A
- SEAT N/A
- Revenue Growth
- KROS 8037.50
- SEAT 13.91
- 52 Week Low
- KROS $9.78
- SEAT $3.24
- 52 Week High
- KROS $73.00
- SEAT $6.41
- Technical
- Relative Strength Index (RSI)
- KROS 24.87
- SEAT 62.13
- Support Level
- KROS $10.95
- SEAT $4.49
- Resistance Level
- KROS $11.63
- SEAT $5.00
- Average True Range (ATR)
- KROS 0.87
- SEAT 0.22
- MACD
- KROS 1.31
- SEAT -0.01
- Stochastic Oscillator
- KROS 30.60
- SEAT 57.14
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About SEAT Vivid Seats Inc.
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale.